Efficacy and Safety of NTI164 in Children and Young Adults With Rett Syndrome

Clinical trial NCT07257978 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07257978
Sponsor: Fenix Innovation Group
Status: NOT_YET_RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

RETT Syndrome With Proven MECP2 Mutation Rett Syndrome

Start date: 2026-07-01
Primary completion: 2028-10-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.